HRT Financial’s Biora Therapeutics, Inc. Common Stock BIOR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-253
Closed -$73K 4029
2022
Q1
$73K Buy
253
+195
+336% +$74K ﹤0.01% 2709
2021
Q4
$30K Buy
+58
New +$41.6K ﹤0.01% 2908

HRT Financial's BIOR Position: Q4 2024 in Review

HRT Financial sold out of Biora Therapeutics, Inc. Common Stock (BIOR) in Q4 2024, closing a stake of 3,380 shares — an estimated $16K sold.

HRT Financial first reported a position in BIOR in Q3 2020 and held it in 8 quarters. The position peaked at $357K in Q1 2021. 0 funds tracked by Wall St. Rank hold BIOR as of Q4 2024.

  • HRT Financial reported no remaining Biora Therapeutics, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
  • HRT Financial sold 3,380 Biora Therapeutics, Inc. Common Stock shares in Q4 2024, an estimated $16K.
  • HRT Financial first reported a position in Biora Therapeutics, Inc. Common Stock in Q3 2020 and held it in 8 quarters.
  • HRT Financial's Biora Therapeutics, Inc. Common Stock position peaked at $357K in Q1 2021.
  • 0 funds tracked by Wall St. Rank held Biora Therapeutics, Inc. Common Stock as of Q4 2024.

Based on HRT Financial's 13F filing for Q4 2024, filed 14 Feb 2025.